Dr Mairead Kearney, Senior Director, Platform Lead, Avelumab, Merck Healthcare KGaA, Germany

Dr Mairead Kearney is a seasoned biopharmaceutical executive and researcher with over 15 years of experience in the industry. In her current role, she oversees and delivers the value demonstration and evidence generation strategies and their global rollout out for avelumab’s in-market indications.

With an educational background in medicine, public health, epidemiology and economics, she is committed to improving patient access and outcomes by demonstrating the value of innovative medicines to patients and healthcare providers. She has co-authored numerous peer-reviewed publications.